checkAd
    Startseite > Aktien > Roche Holding > Nachrichten
    Roche Holding Aktie
    248,30
     
    EUR
    +0,16 %
    +0,40 EUR
    Letzter Kurs 11:03:01 Lang & Schwarz
    246,60
     
    EUR
    42 STK
    Geldkurs 11:03:01
    250,00
     
    EUR
    42 STK
    Briefkurs 11:03:01
    ISIN: CH0012032113 · WKN: 851311 · Schweiz

    Neueste Nachrichten

    [Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
    24.04.24 · globenewswire · Roche Holding
    [Ad hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der Roche-Gruppe steigen im ersten Quartal um 2% (CER); beide Divisionen Pharma und Diagnostics wachsen im hohen einstelligen Bereich ohne COVID-19-Produkte
    24.04.24 · globenewswire · Roche Holding
    FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer
    19.04.24 · globenewswire · Roche Holding
    Roche’s subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MS
    17.04.24 · globenewswire · Roche Holding
    [Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study
    15.04.24 · globenewswire · Roche Holding
    Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
    11.04.24 · globenewswire · Roche Holding
    Roche receives FDA approval for the first molecular test to screen for malaria in blood donors
    26.03.24 · globenewswire · Roche Holding
    Roche Annual General Meeting 2024
    12.03.24 · globenewswire · Roche Holding
    Roche Generalversammlung 2024
    12.03.24 · globenewswire · Roche Holding
    Finanztermine: Dienstag, 12. März
    11.03.24 · BörsenNEWS.de · Assicurazioni Generali
    Wochenvorschau: Wirtschafts-und Finanztermine für KW 11-2024
    07.03.24 · BörsenNEWS.de · Deutsche Boerse
    Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of care
    05.03.24 · globenewswire · Roche Holding